Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 January 2021 | Story Nonsindiso Qwabe | Photo Anja Aucamp
Dr Sekanse Ntsala

Lecturer in the School of Social Sciences and Language Education at the University of Free State, Dr Sekanse Ntsala, collaborated with colleagues from eight universities across South Africa to produce instructional reading strategies for Sesotho and isiZulu students in the Faculty of Education.

The project will see Dr Ntsala partner in the production of learning material in Sesotho and IsiZulu for Foundation and Intermediate phase lecturers, academics, and students. The project is centred in the Centre for African Language Teaching at the University of Johannesburg. 

Designing African language material is a progressive move 

He said there was a gap in the learning material currently being produced, as it was all produced in English, even for African languages. 

"The dilemma is that thus far, all the material that we use for teaching has been written in English. This means that lecturers have to rely on material written in English, and in some instances, they have to translate into the relevant African language. The challenge with translation is that the final product does not always come out the same. You find that even when lecturers have to compile study guides, they still have to rely on the same material. It's a challenge that affects even students themselves, as discussions and assessments have to be done in the African language in question."

He said rather than to translate the content that has been written in English, the collaboration will result in newly created material for Sesotho and IsiZulu.

The two languages were selected as pilot languages; Dr Ntsala said the aim of the project is to expand the creation of material to other languages in order to eliminate English as the main focus in teaching.

"The main rationale is that it's only fair that we have material that will be relevant to a particular language. The manner in which it is happening now is sort of degrading to other languages," he said.

Dr Ntsala said the material would be completed by the end of 2020 and would then go through the process of getting approval from the deaneries of the approved universities, as well as from the Department of Education.

"We are trying to ensure that every language gets recognition in classrooms. Having material that is language-specific is a step in the right direction to ensure that each language is given the respect it deserves."

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept